ACL vs NYR

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

ACL

AUCLINICAL FPO [ACL]

51MEDIUM

NYR

NYRADA CDI FORUS [NYR]

51MEDIUM

Score Breakdown

ACL NYR
Technical
51
49
Catalyst
71
52
Sentiment
50
50
Fundamental
68
34
Momentum
52
75
Risk Gate
36
42

Key Metrics

ACL Metric NYR
$433.7MMarket Cap$135.9M
575KAvg Volume (20d)326K
+6.5%Short InterestN/A
$2.97052-Week High$1.435
$1.83352-Week Low$0.225
+0.0%Daily Change-6.1%
$2.330Reference Price$0.535
+16.7%ROE-71.0%
+3.6%Profit Margin-234.3%

Active Signals

ACL Signals

Trading above both moving averages — the trend is your friend here
Drifting lower — down 3.3% over the last 5 days
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.6x)
EPS estimates revised upward (+10pts)
Post-earnings drift: negative surprise (SUE -10)
New substantial holder(s) (1)

NYR Signals

Stochastic turning bearish from a high level — caution
Golden cross just fired — the short-term trend is overtaking the long-term, which is classically bullish
Volume surging at 2.2x normal while price falls — heavy selling pressure
Beating the Small Ords index — relative strength of 1.27, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Low cash runway (4 quarters) - dilution risk
Very high P/S ratio (57.1x)
Piotroski F-Score weak (3/9, low-confidence approx)

Ask Scout AI to compare ACL and NYR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

IPD vs LGP →CBL vs LGP →ACL vs LGP →IPD vs OCC →CBL vs OCC →
ACL Full Analysis → NYR Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).